Literature DB >> 30854252

Chronic Fatigue Syndrome prevalence is grossly overestimated using Oxford criteria compared to Centers for Disease Control (Fukuda) criteria in a U.S. population study.

James N Baraniuk.   

Abstract

BACKGROUND: Results from treatment studies using the low threshold Oxford criteria for recruitment may have been overgeneralized to patients diagnosed by more stringent CFS criteria.
PURPOSE: To compare the selectivity of Oxford and Fukuda criteria in a U.S. population.
METHODS: Fukuda (Center for Disease Control (CDC)) criteria, as operationalized with the CFS Severity Questionnaire (CFSQ), were included in the nationwide rc2004 HealthStyles survey mailed to 6,175 participants who were representative of the US 2003 Census population. The 9 questionnaire items (CFS symptoms) were crafted into proxies for Oxford criteria (mild fatigue, minimal exclusions) and Fukuda criteria (fatigue plus ≥4 of 8 ancillary criteria at moderate or severe levels with exclusions). The comparative prevalence estimates of CFS were then determined. Severity scores for fatigue were plotted against the sum of severities for the 8 ancillary criteria. The 4 quadrants of scatter diagrams assessed putative healthy controls, CFS, chronic idiopathic fatigue, and CFS-like with insufficient fatigue subjects.
RESULTS: The Oxford criteria designated CFS in 25.5% of 2,004 males and 19.9% of 1,954 females. Based on quadrant analysis, 85% of Oxford-defined cases were inappropriately classified as CFS. Fukuda criteria identified CFS in 2.3% of males and 1.8% of females. DISCUSSION: CFS prevalence using Fukuda criteria and quadrant analysis were near the upper limits of previous epidemiology studies. The CFSQ may have utility for on-line and outpatient screening. The Oxford criteria were untenable because they inappropriately selected healthy subjects with mild fatigue and chronic idiopathic fatigue and mislabeled them as CFS.

Entities:  

Keywords:  Chronic Fatigue Syndrome; chronic idiopathic fatigue; fatigue; myalgic encephalomyelitis; selection criteria

Year:  2017        PMID: 30854252      PMCID: PMC6407870          DOI: 10.1080/21641846.2017.1353578

Source DB:  PubMed          Journal:  Fatigue        ISSN: 2164-1846


  29 in total

1.  Prevalence of self-reported epilepsy or seizure disorder and its associations with self-reported depression and anxiety: results from the 2004 HealthStyles Survey.

Authors:  Rosemarie Kobau; Frank Gilliam; David J Thurman
Journal:  Epilepsia       Date:  2006-11       Impact factor: 5.864

Review 2.  Definitions and aetiology of myalgic encephalomyelitis: how the Canadian consensus clinical definition of myalgic encephalomyelitis works.

Authors:  B M Carruthers
Journal:  J Clin Pathol       Date:  2006-08-25       Impact factor: 3.411

3.  Symptom patterns in long-duration chronic fatigue syndrome.

Authors:  F Friedberg; L Dechene; M J McKenzie; R Fontanetta
Journal:  J Psychosom Res       Date:  2000-01       Impact factor: 3.006

4.  Prevalence and incidence of chronic fatigue syndrome in Wichita, Kansas.

Authors:  Michele Reyes; Rosane Nisenbaum; David C Hoaglin; Elizabeth R Unger; Carol Emmons; Bonnie Randall; John A Stewart; Susan Abbey; James F Jones; Nelson Gantz; Sarah Minden; William C Reeves
Journal:  Arch Intern Med       Date:  2003-07-14

5.  Psychometric properties of the CDC Symptom Inventory for assessment of chronic fatigue syndrome.

Authors:  Dieter Wagner; Rosane Nisenbaum; Christine Heim; James F Jones; Elizabeth R Unger; William C Reeves
Journal:  Popul Health Metr       Date:  2005-07-22

6.  Chronic fatigue syndrome--a clinically empirical approach to its definition and study.

Authors:  William C Reeves; Dieter Wagner; Rosane Nisenbaum; James F Jones; Brian Gurbaxani; Laura Solomon; Dimitris A Papanicolaou; Elizabeth R Unger; Suzanne D Vernon; Christine Heim
Journal:  BMC Med       Date:  2005-12-15       Impact factor: 8.775

7.  An evaluation of exclusionary medical/psychiatric conditions in the definition of chronic fatigue syndrome.

Authors:  James F Jones; Jin-Mann S Lin; Elizabeth M Maloney; Roumiana S Boneva; Urs M Nater; Elizabeth R Unger; William C Reeves
Journal:  BMC Med       Date:  2009-10-12       Impact factor: 8.775

8.  Prevalence of chronic fatigue syndrome in metropolitan, urban, and rural Georgia.

Authors:  William C Reeves; James F Jones; Elizabeth Maloney; Christine Heim; David C Hoaglin; Roumiana S Boneva; Marjorie Morrissey; Rebecca Devlin
Journal:  Popul Health Metr       Date:  2007-06-08

Review 9.  Identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution.

Authors:  William C Reeves; Andrew Lloyd; Suzanne D Vernon; Nancy Klimas; Leonard A Jason; Gijs Bleijenberg; Birgitta Evengard; Peter D White; Rosane Nisenbaum; Elizabeth R Unger
Journal:  BMC Health Serv Res       Date:  2003-12-31       Impact factor: 2.655

10.  Use of medications by people with chronic fatigue syndrome and healthy persons: a population-based study of fatiguing illness in Georgia.

Authors:  Roumiana S Boneva; Jin-Mann S Lin; Elizabeth M Maloney; James F Jones; William C Reeves
Journal:  Health Qual Life Outcomes       Date:  2009-07-20       Impact factor: 3.186

View more
  4 in total

Review 1.  The Updated NICE Guidance Exposed the Serious Flaws in CBT and Graded Exercise Therapy Trials for ME/CFS.

Authors:  Mark Vink; Alexandra Vink-Niese
Journal:  Healthcare (Basel)       Date:  2022-05-12

2.  Evidence-Based Care for People with Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

Authors:  Michael Sharpe; Trudie Chalder; Peter D White
Journal:  J Gen Intern Med       Date:  2021-11-17       Impact factor: 6.473

3.  Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19.

Authors:  Leila Simani; Mahtab Ramezani; Ilad Alavi Darazam; Mastooreh Sagharichi; Mohammad Amin Aalipour; Fatemeh Ghorbani; Hossein Pakdaman
Journal:  J Neurovirol       Date:  2021-02-02       Impact factor: 2.643

Review 4.  Review of the Midbrain Ascending Arousal Network Nuclei and Implications for Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS), Gulf War Illness (GWI) and Postexertional Malaise (PEM).

Authors:  James N Baraniuk
Journal:  Brain Sci       Date:  2022-01-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.